Loading
Latest filing published 02 Jul 2026 for VistaGen Therapeutics, Inc..
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by Reid G. Adler on record concern VistaGen Therapeutics, Inc. In total, 6 filings cover trades dated from 17 August 2022 to 30 June 2026.
No open-market sale appears; the market trades are 1 purchase worth €50k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 5 share grants.
The latest filing, published on 2 July 2026, reports a share grant in VistaGen Therapeutics, Inc. The most recent open-market purchase was published on 19 August 2022, 1,529 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations